We use cookies to improve your experience on this website.

News & Events

DPS Launches Construction Management Division in the U.S. Serving the Life Sciences Industry

Friday 10 June 2016

DPS,  a Framingham-based architecture and engineering firm serving the life sciences industry, officially announced the launch of its Construction Management division in the U.S., as part of the overall growth strategy for the 40+ year old global firm.  Founded in 1974, with its corporate headquarters based in Ireland, DPS opened its Framingham office in 2011 to better serve its pharmaceutical and biotech clients in the Greater Boston and New England area, as well as the U.S.

“The decision to pursue this strategic initiative is to provide our clients with the option of a variety of project delivery models,” said Aidan O’Dwyer, Senior Vice President of Project Operations. “This will allow DPS to offer full EPCMV (engineering, procurement, construction management and validation), design-build, as well as standalone construction management services within the traditional design-bid-build model—providing our clients with comprehensive services throughout a project’s lifecycle.”

Over the past six years, DPS-Framingham has experienced rapid growth, currently employing a staff of over 120 people, offering full architecture and engineering services, commissioning, qualification and validation services for leading global pharmaceutical and biotech companies to include Sanofi Genzyme, AbbVie, Shire, Pfizer, Eli Lilly, Avecia Nitto Denko and Seres Therapeutics.

Carl Bradbury, who joined DPS in January 2016, will lead the construction management initiative. Bradbury brings over 20 years of experience having completed over $1 billion in total project costs for leading pharmaceutical and biotech companies—all of whom are currently DPS clients.  The firm has been performing construction management services since 1996, most of which has been provided in Ireland, Belgium and Spain for global clients such as Pfizer, GlaxoSmithKline, Merck, Bristol-Myers Squibb, Janssen Biologics and Takeda Pharmaceuticals to name a few.  Presently, U.S. construction management services will focus on New England-based clients.  With extensive knowledge in the life sciences industry for retro-fit and Greenfield manufacturing facilities, the firm can provide highly-skilled experts across all discipline. 

“We recognize the growing trend in the market sectors we serve as to the benefit our clients will receive from an integrated supplier who can provide a variety of delivery models,” added O’Dwyer. “Our goal is not to promote one method over the other, but rather we will be able to provide the most appropriate delivery model for every client and project need.”

About DPS

Since 1974, DPS has built a strong global presence by delivering world-class service and developing successful, ongoing client partnerships. For 42 years we have served industries around the world—with our core business focused in the life sciences sector. DPS offers these clients a comprehensive range of services involved in the design, construction, and commissioning & qualification of cGMP manufacturing facilities. With over 1,000 employees worldwide—our highly-skilled and experienced teams can deliver an exceptional level of expertise to our clients.  

Back to top
DPS Group addresses the COVID-19 pandemic:
A message from Frank Keogh, CEO

Find out more Contact Us